Truist Financial Boosts Inari Medical (NASDAQ:NARI) Price Target to $70.00
Inari Medical (NASDAQ:NARI – Free Report) had its price objective raised by Truist Financial from $65.00 to $70.00 in a research report sent to investors on Friday, Benzinga reports. They currently have a hold rating on the stock. Separately, Piper Sandler cut their target price on Inari Medical from $90.00 to $85.00 and set an […]